248 related articles for article (PubMed ID: 28866033)
21. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
[TBL] [Abstract][Full Text] [Related]
22. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
[No Abstract] [Full Text] [Related]
23. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography Study.
Ueki Y; Räber L; Otsuka T; Rai H; Losdat S; Windecker S; Garcia-Garcia HM; Landmesser U; Koolen J; Byrne R; Haude M; Joner M
Circ Cardiovasc Interv; 2020 Mar; 13(3):e008657. PubMed ID: 32093514
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
26. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
27. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
[No Abstract] [Full Text] [Related]
28. First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy.
Ribichini F; Scarsini R; Zanetti C; Pesarini G
JACC Cardiovasc Interv; 2017 Jun; 10(12):1270-1272. PubMed ID: 28579240
[No Abstract] [Full Text] [Related]
29. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
[TBL] [Abstract][Full Text] [Related]
30. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
Maeremans J; Verhaert D; Pereira B; Frambach P; Van Mieghem C; Barbato E; Willems E; Vrolix M; Dens J
Catheter Cardiovasc Interv; 2018 Sep; 92(3):488-496. PubMed ID: 29068171
[TBL] [Abstract][Full Text] [Related]
31. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
[No Abstract] [Full Text] [Related]
32. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
[No Abstract] [Full Text] [Related]
33. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
34. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
[No Abstract] [Full Text] [Related]
35. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
Longo G; Granata F; Capodanno D; Ohno Y; Tamburino CI; Capranzano P; La Manna A; Francaviglia B; Gargiulo G; Tamburino C
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1150-61. PubMed ID: 25573598
[TBL] [Abstract][Full Text] [Related]
36. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
37. Coronary Stent Fracture: Still a Cause of Stent Failure.
Pazolini V; Campos C; Caixeta A
J Invasive Cardiol; 2019 May; 31(5):E89-E90. PubMed ID: 31034440
[TBL] [Abstract][Full Text] [Related]
38. Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds.
Ohno Y; Mangiameli A; Attizzani GF; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e11-2. PubMed ID: 25499307
[No Abstract] [Full Text] [Related]
39. Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
Paradies V; Smits PC; Vachojannis GJ; Royaards KJ; Wassing J; van der Ent M
Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):279-285. PubMed ID: 29066339
[TBL] [Abstract][Full Text] [Related]
40. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.
Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A
JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
